Publisher
Springer Berlin Heidelberg
Reference55 articles.
1. Arzneimittelkommission der deutschen Ärzteschaft (2006): Arzneiverordnungen. Empfehlungen zur rationalen Pharmakotherapie. 21. Auflage, Deutscher ÄrzteVerlag Köln, S. 907–921.
2. Beker JA, Bianchi Porro G, Bigard MA, Delle Fave G, Devis G, Gouerou H, Maier C (1995): Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol 7: 407–410.
3. Bleichner G, Bléhaut H, Mentec H, Moyse D (1997): Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. Intensive Care Med 23: 517–523.
4. Bombardier C, Laine L, Reicin A et al (2000): Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 343: 1520–1528.
5. Borowitz D, Goss CH, Stevens C, Hayes D, Newman L, O’Rourke A, Konstan MW, Wagener J, Moss R, Hendeles L, Orenstein D, Ahrens R, Oermann CM, Aitken ML, Mahl TC, Young KR, Dunitz J, Murray FT (2006): Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients. Pancreas 32: 258–263.